SecBot SecBot
6-K ·Filed Sep 15, 2026
DA

DAVI

DAVION HEALTHCARE PLC
NEUTRAL
Impact 5/10
Horizondays Processed1mo ago SEC0001683168-26-007122
Notable filing: 6-K
Actionable Insight • Neutral

Davion Healthcare announced the admission of a £30 million senior secured bond (10.5% coupon, 5-year term) issued by its subsidiary Davion Healthcare Finance Ltd to the Vienna MTF. Proceeds will fund acquisitions of established, cash-generative healthcare businesses across medical devices, diagnostics, distribution, and services. This provides dedicated capital to execute its acquisition-led growth strategy, addressing prior cash constraints (only €1,058 cash at FY2025) and signaling management's commitment to expansion. However, the high 10.5% coupon and reliance on debt raise financial risk, and the company remains pre-revenue with a material weakness in internal controls.

DirectionNeutral
Confidencemedium
Horizondays

Price Chart

Loading chart...

Executive Summary

Davion Healthcare announced the admission of a £30 million senior secured bond (10.5% coupon, 5-year term) issued by its subsidiary Davion Healthcare Finance Ltd to the Vienna MTF. Proceeds will fund acquisitions of established, cash-generative healthcare businesses across medical devices, diagnostics, distribution, and services. This provides dedicated capital to execute its acquisition-led growth strategy, addressing prior cash constraints (only €1,058 cash at FY2025) and signaling management's commitment to expansion. However, the high 10.5% coupon and reliance on debt raise financial risk, and the company remains pre-revenue with a material weakness in internal controls.

Financial Impact

Not specified

Risk Factors

  • High debt burden with 10.5% coupon could strain cash flows if acquisitions underperform
  • Pre-revenue status and material weakness in internal controls increase execution risk
  • Acquisition integration risks and potential overpayment
  • Vienna MTF listing offers limited liquidity and regulatory protection
  • Dilution risk if additional equity is needed

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001683168-26-007122
Document: davion_ex9901.htm0001683168-26-007122
Document: 0001683168-26-007122-index-headers.html0001683168-26-007122
Document: 0001683168-26-007122-index.html0001683168-26-007122
Document: 0001683168-26-007122.txt0001683168-26-007122
4 reports for DAVI
Performance horizon
Filters
Rows
Reports for DAVI — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
NEUTRAL ★ 4/10
$5.10awaiting T+20—$6.00 (+17.65%)
Oct 20, 2026
5d ago
6-K
NEUTRAL ★ 4/10
—awaiting T+20——
Sep 15, 2026
5w ago
6-K
NEUTRAL ★ 5/10
—awaiting T+20——
Apr 30, 2026
25w ago
20-F
NEUTRAL ★ 5/10
—awaiting T+20——
Showing 4 of 4

US Market Status

Market Closed — Opens in 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026